JP2025502023A5 - - Google Patents
Info
- Publication number
- JP2025502023A5 JP2025502023A5 JP2024540710A JP2024540710A JP2025502023A5 JP 2025502023 A5 JP2025502023 A5 JP 2025502023A5 JP 2024540710 A JP2024540710 A JP 2024540710A JP 2024540710 A JP2024540710 A JP 2024540710A JP 2025502023 A5 JP2025502023 A5 JP 2025502023A5
- Authority
- JP
- Japan
- Prior art keywords
- deuterium
- pirfenidone
- concentrated
- total daily
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (31)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263296818P | 2022-01-05 | 2022-01-05 | |
| US202263296826P | 2022-01-05 | 2022-01-05 | |
| US202263296843P | 2022-01-05 | 2022-01-05 | |
| US63/296,818 | 2022-01-05 | ||
| US63/296,826 | 2022-01-05 | ||
| US63/296,843 | 2022-01-05 | ||
| US202263326132P | 2022-03-31 | 2022-03-31 | |
| US202263326129P | 2022-03-31 | 2022-03-31 | |
| US63/326,129 | 2022-03-31 | ||
| US63/326,132 | 2022-03-31 | ||
| US202263341279P | 2022-05-12 | 2022-05-12 | |
| US202263341269P | 2022-05-12 | 2022-05-12 | |
| US202263341281P | 2022-05-12 | 2022-05-12 | |
| US63/341,269 | 2022-05-12 | ||
| US63/341,279 | 2022-05-12 | ||
| US63/341,281 | 2022-05-12 | ||
| US202263341828P | 2022-05-13 | 2022-05-13 | |
| US63/341,828 | 2022-05-13 | ||
| US202263352107P | 2022-06-14 | 2022-06-14 | |
| US63/352,107 | 2022-06-14 | ||
| US202263356653P | 2022-06-29 | 2022-06-29 | |
| US63/356,653 | 2022-06-29 | ||
| US202263374362P | 2022-09-01 | 2022-09-01 | |
| US63/374,362 | 2022-09-01 | ||
| US202263403481P | 2022-09-02 | 2022-09-02 | |
| US63/403,481 | 2022-09-02 | ||
| US202263431530P | 2022-12-09 | 2022-12-09 | |
| US63/431,530 | 2022-12-09 | ||
| US202263432208P | 2022-12-13 | 2022-12-13 | |
| US63/432,208 | 2022-12-13 | ||
| PCT/US2023/060185 WO2023133476A1 (en) | 2022-01-05 | 2023-01-05 | Methods of treating idiopathic pulmonary fibrosis with deupirfenidone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025502023A JP2025502023A (ja) | 2025-01-24 |
| JP2025502023A5 true JP2025502023A5 (enExample) | 2026-08-13 |
Family
ID=87074293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024540710A Pending JP2025502023A (ja) | 2022-01-05 | 2023-01-05 | デューピルフェニドンにより特発性肺線維症を治療する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240358690A1 (enExample) |
| EP (1) | EP4460305A4 (enExample) |
| JP (1) | JP2025502023A (enExample) |
| KR (1) | KR20240131352A (enExample) |
| AU (1) | AU2023205787A1 (enExample) |
| CA (1) | CA3239301A1 (enExample) |
| IL (1) | IL314022A (enExample) |
| MX (1) | MX2024008476A (enExample) |
| WO (1) | WO2023133476A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023192646A1 (en) * | 2022-03-31 | 2023-10-05 | Puretech Lyt 100, Inc. | Methods of treating fibrotic- and collagen-mediated diseases and disorders with deupirfenidone |
| WO2026133158A1 (en) * | 2024-12-16 | 2026-06-25 | Puretech Lyt 100, Inc. | Deupirfenidone for use for treating interstitial lung diseases and other fibrotic-mediated pulmonary diseases |
| WO2026133157A1 (en) * | 2024-12-16 | 2026-06-25 | Puretech Lyt 100, Inc. | Deupirfenidone for use for treating idiopathic pulmonary fibrosis |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080287508A1 (en) * | 2007-05-18 | 2008-11-20 | Intermune, Inc. | Altering pharmacokinetics of pirfenidone therapy |
| AU2008265595B2 (en) * | 2007-06-20 | 2014-12-04 | PureTech LYT 100 Inc. | Substituted N-Aryl pyridinones as fibrotic inhibitors |
| US20090131485A1 (en) * | 2007-09-10 | 2009-05-21 | Concert Pharmaceuticals, Inc. | Deuterated pirfenidone |
| IL319182A (en) * | 2018-09-14 | 2025-04-01 | Puretech Lyt 100 Inc | Deuterium-enriched pirfenidone and methods of using it |
| US20250114341A1 (en) * | 2018-09-14 | 2025-04-10 | Puretech Lyt 100, Inc. | Methods of treating idiopathic pulmonary fibrosis with deupirfenidone |
| US20230129866A1 (en) * | 2020-03-13 | 2023-04-27 | Puretech Lyt 100, Inc. | Methods of treating respiratory disease with deupirfenidone |
-
2023
- 2023-01-05 AU AU2023205787A patent/AU2023205787A1/en active Pending
- 2023-01-05 KR KR1020247022244A patent/KR20240131352A/ko active Pending
- 2023-01-05 CA CA3239301A patent/CA3239301A1/en active Pending
- 2023-01-05 MX MX2024008476A patent/MX2024008476A/es unknown
- 2023-01-05 IL IL314022A patent/IL314022A/en unknown
- 2023-01-05 WO PCT/US2023/060185 patent/WO2023133476A1/en not_active Ceased
- 2023-01-05 EP EP23737759.3A patent/EP4460305A4/en active Pending
- 2023-01-05 JP JP2024540710A patent/JP2025502023A/ja active Pending
-
2024
- 2024-06-28 US US18/758,783 patent/US20240358690A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024540183A5 (enExample) | ||
| JP2024516371A5 (enExample) | ||
| JP2015508749A5 (enExample) | ||
| JP2015145426A5 (enExample) | ||
| JP2010515715A5 (enExample) | ||
| JP2018534348A5 (enExample) | ||
| JP2009533356A5 (enExample) | ||
| JP2009502743A5 (enExample) | ||
| JP2020519661A5 (enExample) | ||
| JP2017222722A5 (enExample) | ||
| JPWO2023195530A5 (enExample) | ||
| JP2009514874A5 (enExample) | ||
| JP2007533687A5 (enExample) | ||
| JP2022502500A5 (enExample) | ||
| JP2024515829A5 (enExample) | ||
| JP2022524997A5 (enExample) | ||
| JP2010522756A5 (enExample) | ||
| JP2024510436A5 (enExample) | ||
| JP2011505356A5 (enExample) | ||
| JP2025508406A5 (enExample) | ||
| JP2024541569A5 (enExample) | ||
| JP2022552520A5 (enExample) | ||
| RU2018136580A (ru) | Цитратная соль (s)-4-((s)-3-фтор-3-(2-(5,6,7,8-тетрагидро-1,8-нафтиридин-2-ил)этил)пирролидин-1-ил)-3-(3-(2-метоксиэтокси)фенил)бутановой кислоты | |
| JP2016522254A5 (enExample) | ||
| JP2023545372A5 (enExample) |